Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Avantor, Inc. stock logo
AVTR
Avantor
$25.66
+5.1%
$24.96
$16.63
$26.16
$17.40B1.375.70 million shs5.61 million shs
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$285.62
+2.0%
$328.92
$261.59
$473.50
$8.15B0.87203,662 shs250,549 shs
Illumina, Inc. stock logo
ILMN
Illumina
$124.46
+3.5%
$132.98
$89.00
$229.58
$19.82B1.191.75 million shs1.30 million shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Avantor, Inc. stock logo
AVTR
Avantor
+1.27%-1.23%-6.39%+10.48%+21.12%
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
+0.06%-6.82%-20.13%-11.21%-40.09%
Illumina, Inc. stock logo
ILMN
Illumina
+2.40%-0.75%-12.38%-14.56%-47.18%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Avantor, Inc. stock logo
AVTR
Avantor
4.2713 of 5 stars
2.42.00.03.23.22.53.1
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
4.6603 of 5 stars
3.44.00.04.21.73.31.9
Illumina, Inc. stock logo
ILMN
Illumina
4.6466 of 5 stars
3.23.00.04.23.33.31.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Avantor, Inc. stock logo
AVTR
Avantor
2.75
Moderate Buy$26.714.13% Upside
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
2.80
Moderate Buy$468.0063.85% Upside
Illumina, Inc. stock logo
ILMN
Illumina
2.32
Hold$167.7034.74% Upside

Current Analyst Ratings

Latest BIO, ILMN, and AVTR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/18/2024
Avantor, Inc. stock logo
AVTR
Avantor
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$23.00 ➝ $25.00
4/10/2024
Avantor, Inc. stock logo
AVTR
Avantor
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$27.00 ➝ $30.00
4/10/2024
Illumina, Inc. stock logo
ILMN
Illumina
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetUnderweight ➝ Underweight$85.00 ➝ $100.00
4/10/2024
Illumina, Inc. stock logo
ILMN
Illumina
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$170.00
4/9/2024
Illumina, Inc. stock logo
ILMN
Illumina
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$253.00
4/4/2024
Avantor, Inc. stock logo
AVTR
Avantor
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$26.00 ➝ $28.00
4/3/2024
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$400.00 ➝ $365.00
3/20/2024
Illumina, Inc. stock logo
ILMN
Illumina
OTR Global
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingPositive ➝ Mixed
2/16/2024
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$395.00 ➝ $420.00
2/16/2024
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$484.00 ➝ $480.00
2/15/2024
Avantor, Inc. stock logo
AVTR
Avantor
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$25.00 ➝ $29.00
(Data available from 4/23/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Avantor, Inc. stock logo
AVTR
Avantor
$6.97B2.50$1.79 per share14.36$7.77 per share3.30
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$2.67B3.05$12.36 per share23.11$306.51 per share0.93
Illumina, Inc. stock logo
ILMN
Illumina
$4.50B4.40$3.80 per share32.77$36.18 per share3.44

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Avantor, Inc. stock logo
AVTR
Avantor
$321.10M$0.4853.4520.692.454.61%14.11%5.50%4/26/2024 (Confirmed)
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
-$637.32M-$21.49N/A24.92N/A-23.86%3.90%2.77%5/7/2024 (Confirmed)
Illumina, Inc. stock logo
ILMN
Illumina
-$1.16B-$7.34N/A51.86N/A-25.78%2.20%1.25%5/2/2024 (Confirmed)

Latest BIO, ILMN, and AVTR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2024N/A
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$2.04N/A-$2.04N/AN/AN/A  
5/2/2024N/A
Illumina, Inc. stock logo
ILMN
Illumina
$0.03N/A-$0.03N/AN/AN/A  
4/26/2024N/A
Avantor, Inc. stock logo
AVTR
Avantor
$0.20N/A-$0.20N/AN/AN/A  
2/15/2024Q4 2023
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
$2.93$3.10+$0.17-$5.94$685.00 million$681.18 million      
2/14/202412/31/2023
Avantor, Inc. stock logo
AVTR
Avantor
$0.22$0.25+$0.03$0.35$1.70 billion$1.72 billion      
2/8/2024Q4 23
Illumina, Inc. stock logo
ILMN
Illumina
$0.0130$0.14+$0.1270$1.39$1.09 billion$1.12 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Avantor, Inc. stock logo
AVTR
Avantor
N/AN/AN/AN/AN/A
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
N/AN/AN/AN/AN/A
Illumina, Inc. stock logo
ILMN
Illumina
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Avantor, Inc. stock logo
AVTR
Avantor
1.00
1.61
1.05
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
0.14
5.83
4.34
Illumina, Inc. stock logo
ILMN
Illumina
0.26
1.66
1.29

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Avantor, Inc. stock logo
AVTR
Avantor
95.08%
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
65.24%
Illumina, Inc. stock logo
ILMN
Illumina
89.42%

Insider Ownership

CompanyInsider Ownership
Avantor, Inc. stock logo
AVTR
Avantor
1.30%
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
17.50%
Illumina, Inc. stock logo
ILMN
Illumina
0.17%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Avantor, Inc. stock logo
AVTR
Avantor
14,500678.28 million669.46 millionOptionable
Bio-Rad Laboratories, Inc. stock logo
BIO
Bio-Rad Laboratories
8,03028.52 million23.53 millionOptionable
Illumina, Inc. stock logo
ILMN
Illumina
9,300159.26 million158.98 millionOptionable

BIO, ILMN, and AVTR Headlines

SourceHeadline
Illumina (NASDAQ:ILMN) investors are sitting on a loss of 71% if they invested three years agoIllumina (NASDAQ:ILMN) investors are sitting on a loss of 71% if they invested three years ago
finance.yahoo.com - April 23 at 9:24 AM
Illumina, Inc. (NASDAQ:ILMN) Shares Acquired by Duality Advisers LPIllumina, Inc. (NASDAQ:ILMN) Shares Acquired by Duality Advisers LP
marketbeat.com - April 22 at 11:53 AM
Illumina, Inc. (NASDAQ:ILMN) Shares Purchased by North Star Asset Management Inc.Illumina, Inc. (NASDAQ:ILMN) Shares Purchased by North Star Asset Management Inc.
marketbeat.com - April 21 at 10:18 PM
Zurcher Kantonalbank Zurich Cantonalbank Boosts Position in Illumina, Inc. (NASDAQ:ILMN)Zurcher Kantonalbank Zurich Cantonalbank Boosts Position in Illumina, Inc. (NASDAQ:ILMN)
marketbeat.com - April 20 at 6:34 AM
Illumina, Inc. (NASDAQ:ILMN) Given Consensus Recommendation of "Hold" by BrokeragesIllumina, Inc. (NASDAQ:ILMN) Given Consensus Recommendation of "Hold" by Brokerages
americanbankingnews.com - April 20 at 2:18 AM
20 Countries with the Highest Cancer Survival Rates in the World20 Countries with the Highest Cancer Survival Rates in the World
finance.yahoo.com - April 19 at 2:21 PM
Can Illumina (ILMN) Keep the Earnings Surprise Streak Alive?Can Illumina (ILMN) Keep the Earnings Surprise Streak Alive?
zacks.com - April 19 at 1:15 PM
Illumina, Inc. (NASDAQ:ILMN) Shares Acquired by Daiwa Securities Group Inc.Illumina, Inc. (NASDAQ:ILMN) Shares Acquired by Daiwa Securities Group Inc.
marketbeat.com - April 19 at 7:39 AM
Illumina, Inc. (ILMN)Illumina, Inc. (ILMN)
finance.yahoo.com - April 18 at 11:03 PM
Illumina: Engineering a Cool Career in Biotech - and Volunteering Along the WayIllumina: Engineering a Cool Career in Biotech - and Volunteering Along the Way
finanznachrichten.de - April 18 at 6:03 PM
Engineering a Cool Career in Biotech - and Volunteering Along the WayEngineering a Cool Career in Biotech - and Volunteering Along the Way
finance.yahoo.com - April 18 at 6:03 PM
AIA Group Ltd Purchases 10,378 Shares of Illumina, Inc. (NASDAQ:ILMN)AIA Group Ltd Purchases 10,378 Shares of Illumina, Inc. (NASDAQ:ILMN)
marketbeat.com - April 18 at 3:54 PM
Illumina: Evidence Supports Sequencing As First-Line Rare Disease DiagnosticIllumina: Evidence Supports Sequencing As First-Line Rare Disease Diagnostic
finanznachrichten.de - April 17 at 2:57 PM
Evidence Supports Sequencing As First-Line Rare Disease DiagnosticEvidence Supports Sequencing As First-Line Rare Disease Diagnostic
finance.yahoo.com - April 17 at 2:57 PM
Traders Purchase High Volume of Put Options on Illumina (NASDAQ:ILMN)Traders Purchase High Volume of Put Options on Illumina (NASDAQ:ILMN)
americanbankingnews.com - April 17 at 2:38 AM
What the Options Market Tells Us About IlluminaWhat the Options Market Tells Us About Illumina
benzinga.com - April 16 at 3:32 PM
Illumina Target of Unusually Large Options Trading (NASDAQ:ILMN)Illumina Target of Unusually Large Options Trading (NASDAQ:ILMN)
marketbeat.com - April 16 at 10:35 AM
Louisiana State Employees Retirement System Makes New Investment in Illumina, Inc. (NASDAQ:ILMN)Louisiana State Employees Retirement System Makes New Investment in Illumina, Inc. (NASDAQ:ILMN)
marketbeat.com - April 16 at 6:50 AM
Illumina receives European Commission approval to divest GRAILIllumina receives European Commission approval to divest GRAIL
pharmabiz.com - April 15 at 8:36 PM
European Commission approves Illumina’s proposed Grail splitEuropean Commission approves Illumina’s proposed Grail split
medtechdive.com - April 15 at 3:36 PM
International Assets Investment Management LLC Purchases 32,672 Shares of Illumina, Inc. (NASDAQ:ILMN)International Assets Investment Management LLC Purchases 32,672 Shares of Illumina, Inc. (NASDAQ:ILMN)
marketbeat.com - April 15 at 4:44 AM
WCM Investment Management LLC Acquires 141,503 Shares of Illumina, Inc. (NASDAQ:ILMN)WCM Investment Management LLC Acquires 141,503 Shares of Illumina, Inc. (NASDAQ:ILMN)
marketbeat.com - April 14 at 10:36 AM
Ingalls & Snyder LLC Invests $2.35 Million in Illumina, Inc. (NASDAQ:ILMN)Ingalls & Snyder LLC Invests $2.35 Million in Illumina, Inc. (NASDAQ:ILMN)
marketbeat.com - April 13 at 10:44 AM
EU Approves Illuminas Plan to Shed Cancer-Test Maker Grail -- 2nd UpdateEU Approves Illumina's Plan to Shed Cancer-Test Maker Grail -- 2nd Update
marketwatch.com - April 12 at 3:50 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Avantor logo

Avantor

NYSE:AVTR
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Bio-Rad Laboratories logo

Bio-Rad Laboratories

NYSE:BIO
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Illumina logo

Illumina

NASDAQ:ILMN
Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.